Heron Selling General Administrative from 2010 to 2024

HRTX Stock  USD 1.19  0.03  2.59%   
Heron Therapeuti Selling General Administrative yearly trend continues to be fairly stable with very little volatility. Selling General Administrative is likely to outpace its year average in 2024. During the period from 2010 to 2024, Heron Therapeuti Selling General Administrative regression line of annual values had r-squared of  0.87 and arithmetic mean of  28,893,913. View All Fundamentals
 
Selling General Administrative  
First Reported
1995-06-30
Previous Quarter
13.9 M
Current Value
12.4 M
Quarterly Volatility
4.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 110. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Heron Therapeuti over the last few years. It is Heron Therapeuti's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Heron Selling General Administrative Regression Statistics

Arithmetic Mean28,893,913
Geometric Mean23,772,234
Coefficient Of Variation51.04
Mean Deviation12,272,719
Median29,263,000
Standard Deviation14,748,239
Sample Variance217.5T
Range48M
R-Value0.93
Mean Square Error29.6T
R-Squared0.87
Slope3,082,110
Total Sum of Squares3045.1T

Heron Selling General Administrative History

202451.5 M
202349 M
202237.4 M
202140.2 M
202042.2 M
201937.9 M
201829.3 M

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's Selling General Administrative, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative49 M51.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.